These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1697 related items for PubMed ID: 16786000

  • 21. The role of epigenetic inactivation of 14-3-3sigma in human cancer.
    Lodygin D, Hermeking H.
    Cell Res; 2005 Apr; 15(4):237-46. PubMed ID: 15857578
    [Abstract] [Full Text] [Related]

  • 22. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells.
    Kim TY, Jong HS, Song SH, Dimtchev A, Jeong SJ, Lee JW, Kim TY, Kim NK, Jung M, Bang YJ.
    Oncogene; 2003 Jun 19; 22(25):3943-51. PubMed ID: 12813468
    [Abstract] [Full Text] [Related]

  • 23. Aberrant promoter methylation of the ABCG2 gene in renal carcinoma.
    To KK, Zhan Z, Bates SE.
    Mol Cell Biol; 2006 Nov 19; 26(22):8572-85. PubMed ID: 16954373
    [Abstract] [Full Text] [Related]

  • 24. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21.
    Derks S, Bosch LJ, Niessen HE, Moerkerk PT, van den Bosch SM, Carvalho B, Mongera S, Voncken JW, Meijer GA, de Bruïne AP, Herman JG, van Engeland M.
    Carcinogenesis; 2009 Jun 19; 30(6):1041-8. PubMed ID: 19329758
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer.
    Wang LG, Beklemisheva A, Liu XM, Ferrari AC, Feng J, Chiao JW.
    Mol Carcinog; 2007 Jan 19; 46(1):24-31. PubMed ID: 16921492
    [Abstract] [Full Text] [Related]

  • 30. Sensitizing hormone-refractory prostate cancer cells to drug treatment by targeting 14-3-3sigma.
    Han B, Xie H, Chen Q, Zhang JT.
    Mol Cancer Ther; 2006 Apr 19; 5(4):903-12. PubMed ID: 16648560
    [Abstract] [Full Text] [Related]

  • 31. Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells.
    Lin X, Nelson WG.
    Cancer Res; 2003 Jan 15; 63(2):498-504. PubMed ID: 12543808
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
    Liu WB, Han F, Du XH, Jiang X, Li YH, Liu Y, Chen HQ, Ao L, Cui ZH, Cao J, Liu JY.
    Int J Cancer; 2014 Mar 15; 134(6):1311-22. PubMed ID: 24037716
    [Abstract] [Full Text] [Related]

  • 36. Epigenetic DNA methylation of antioxidative stress regulator NRF2 in human prostate cancer.
    Khor TO, Fuentes F, Shu L, Paredes-Gonzalez X, Yang AY, Liu Y, Smiraglia DJ, Yegnasubramanian S, Nelson WG, Kong AN.
    Cancer Prev Res (Phila); 2014 Dec 15; 7(12):1186-97. PubMed ID: 25266896
    [Abstract] [Full Text] [Related]

  • 37. Specific association between the methyl-CpG-binding domain protein 2 and the hypermethylated region of the human telomerase reverse transcriptase promoter in cancer cells.
    Chatagnon A, Bougel S, Perriaud L, Lachuer J, Benhattar J, Dante R.
    Carcinogenesis; 2009 Jan 15; 30(1):28-34. PubMed ID: 18952593
    [Abstract] [Full Text] [Related]

  • 38. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.
    Lin X, Asgari K, Putzi MJ, Gage WR, Yu X, Cornblatt BS, Kumar A, Piantadosi S, DeWeese TL, De Marzo AM, Nelson WG.
    Cancer Res; 2001 Dec 15; 61(24):8611-6. PubMed ID: 11751372
    [Abstract] [Full Text] [Related]

  • 39. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y, Brena RM, Hackanson B, Morrison C, Otterson GA, Plass C.
    J Natl Cancer Inst; 2006 Mar 15; 98(6):396-406. PubMed ID: 16537832
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 85.